News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
RECOVER-TLC announces public comment period for upcoming clinical trial
Patients, caregivers, and researchers will have 2 weeks to provide input on plans to test whether glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can help improve Long COVID symptoms.
Announcement
162 Results
162 Results
Reviewing RECOVER’s impact in 2024
In 2024, RECOVER continued to advance scientific understanding of Long COVID through observational studies, clinical trials, and community engagement.
Feature
RECOVER’s tissue pathology (autopsy) study makes unique contributions to Long COVID research
Using a large and diverse collection of tissue samples, experts in how diseases affect different parts of the body will explore the underlying causes of Long COVID.
Feature
NIH directors highlight RECOVER’s progress and impact
Editorial by NIH leaders shares how RECOVER has worked and will continue working to ease the suffering of those living with Long COVID.
Announcement
NIH adds funds to Long COVID research, advances work on new clinical trials
The $662 million in funds received in 2024 will ensure that researchers can continue making progress toward understanding, diagnosing, preventing, and treating Long COVID through 2029.
News Release
R3 Seminar Recap: Vaccine response and time to recovery from COVID-19 in a multi-cohort collaborative (C4R)
During the November 12th RECOVER Research Review (R3) Seminar, researchers described how they are studying people’s health and habits both before and during the pandemic to answer important questions about COVID-19 and its long-term effects. Specifically, two studies using data collected by the Collaborative Cohort of Cohorts for COVID-19 Research (C4R) have identified several different factors that could impact the protective effects of COVID-19 vaccines.
R3 Seminar Recap
NIH hosts December 3 webinar to help researchers use RECOVER data
Researchers can learn how to access and use data from RECOVER’s pediatric observational study during the next BioData Catalyst® (BDC) Community Hours event, scheduled for Tuesday, December 3rd, 2024, at 1:00 pm EST.
Announcement
Insights from RECOVER’s pediatric study can inform future clinical trials
Findings from RECOVER’s pediatric observational study are an important first step toward including children in Long COVID clinical trials.
Feature
First webinar of Long COVID treatment initiative highlights early progress
On November 21, NIAID and FNIH launched its first in a series of online webinars highlighting recent progress in the new Researching COVID to Enhance Recovery - Treating Long COVID (RECOVER-TLC) program.
News Release